Investorideas.com

Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS


 

The Investorideas.com Newswire: Breaking stock market and investing news

Get our Investorideas.com news feed today and/or add to your site

Get our Investorideas.com full text RSS news feed and/or add to your site

News Partners:

Investorideas PR Connect News: https://pr.investorideas.com


Investor Ideas Newswire:

Stock News and Industry News

Slight Increase in Oil Prices Due to Expectations of Rate Cuts and Impact of Hurricane Francine

September 17, 2024 (Investorideas.com Newswire) The oil market experienced a moderate price increase due to factors such as the potential reduction in interest rates and the supply disruption caused by Hurricane Francine.


Headline retail sales better than expected

September 17, 2024 (Investorideas.com Newswire) "The August US retail sales report, the final top-tier data point before tomorrow's eagerly-anticipated FOMC decision, showed headline sales rising by 0.1%


Natural Gas certainly looks set to increase in price

September 17, 2024 (Investorideas.com Newswire) La Nina is favored to emerge in September-November (71% chance) and is expected to persist through January-March 2025


The Future of Bitcoin: Will Donald Trump Revolutionize the Cryptocurrency Market with the Launch of Liberty Financial?

September 17, 2024 (Investorideas.com Newswire) Bitcoin experienced a modest correction yesterday, opening today, Tuesday, at $58,876, recording a 1% decline and stabilizing below the critical psychological level of $60,000.


Bitcoin Sees Uptick After Three Days of Losses

September 17, 2024 (Investorideas.com Newswire) After three consecutive days of losses, Bitcoin was ticking up.


Gold Near Record High on Fed Rate Cut Expectations and U.S. Election Risks

September 17, 2024 (Investorideas.com Newswire) Gold prices remained near record highs, supported by a weaker dollar and growing expectations of a major interest rate cut from the Federal Reserve.


Euro rises for fourth day despite collapse in sentiment over regional economy

September 17, 2024 (Investorideas.com Newswire) The euro is heading for relative stability and the euro is up 0.06% against the US dollar after rising for the past four days.


What's to Run on FOMC

September 17, 2024 (Investorideas.com Newswire) SP 500 rose on Sep 50bp cut boost to 2/3 odds


Breaking Mining Stock News: New Destiny Mining (TSXV: NED) Drilling Hole 9 at the Jim Kelly Gold Zone - Treasure Mountain Silver Project, Hope BC

Vancouver, British Columbia - September 17, 2024 (Investorideas.com Newswire) New Destiny Mining Corp. (TSXV: NED), (the "Company" or "NED") provides a further update on its 2024 drilling program at the Treasure Mountain project, near Princeton, BC.


Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at Virtual Investor Conferences in September

SAN DIEGO - September 17, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that management will present at the following virtual investor conferences in September


Cancer's Solid Tumors Market - the Stocks to Watch

September 17, 2024 (Investorideas.com Newswire) Stocks mentioned-Aethlon Medical, Inc. (Nasdaq: AEMD), Immuneering (Nasdaq: IMRX), Merck (NYSE: MRK), AstraZeneca (Nasdaq: AZN) Roche (OTCQX: RHHBY).


Bitcoin fails to hold $59,000 amid strong downward pressure

September 16, 2024 (Investorideas.com Newswire) Bitcoin remains below $59,000 as it continues to slide since last Saturday.


Yen Hits Year-High as Fed Rate Cut Bets Weaken Dollar

September 16, 2024 (Investorideas.com Newswire) The yen reached its highest level in over a year on Monday against the dollar.


Gold hits record highs as half-point rate cut probability increases

September 17, 2024 (Investorideas.com Newswire) Gold is touching more record highs today at $2,589 per ounce in spot trading.


Gold in the Week of the Cut

September 16, 2024 (Investorideas.com Newswire) Fed's cut is approaching - but will gold really rally after it?


Are Stocks Overheating?

September 16, 2024 (Investorideas.com Newswire) Stock prices continued their uptrend on Friday, with the SP 500 gaining 0.54% and breaking above the 5,600 level.


Three-quarters of Brits are on track to fall short of retirement funds

September 16, 2024 (Investorideas.com Newswire) Almost three-quarters (74%) of Brits, both in the UK and abroad, are not on track to retire with sufficient funds to maintain their current lifestyle


Short Squeeze, Anyone?

September 16, 2024 (Investorideas.com Newswire) One more day of SP 500 gains extension almost to the neckline of Sunday discussed inverted HS.


Breaking Renewable Energy Stock News: KULR (NYSE:KULR) Releases New KULR ONE Space Presentation, CTO to Participate in Upcoming Live Reddit Q and A Discussion

Houston - September 16, 2024 (Investorideas.com Newswire) KULR Technology Group, Inc. (NYSE American: KULR), a global leader in sustainable energy management, today unveiled its new KULR ONE Space presentation on its website at www.kulrtechnology.com.


Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial

SAN DIEGO - September 16, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that the Cancer Clinical Trial Unit at Royal Adelaide Hospital was activated on September 10, 2024 to begin screening and enrolling patients in its safety, feasibility and dose-finding clinical trial of the Hemopurifier in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda (pembrolizumab) or Opdivo (nivolumab) (AEMD-2022-06 Hemopurifier Study).


Subscribe to Investor Ideas Newswire

Investorideas.com newswire stock news, press releases and industry news in leading sectors including environment and water.

Publish Your News Today at Investor Ideas